Literature DB >> 12884973

Mice overexpressing CRH show reduced responsiveness in plasma corticosterone after a5-HT1A receptor challenge.

M M van Gaalen1, J H M Reul, A Gesing, M P Stenzel-Poore, F Holsboer, T Steckler.   

Abstract

Corticotropin-releasing hormone (CRH) overproduction and serotonergic dysfunction have both been implicated in a range of psychiatric disorders, such as anxiety and depression, and several studies have shown interactions between these two neurotransmitter systems. In this study, we investigated the effects of CRH challenge on hypothalamo-pituitary-adrenal (HPA) axis activity in female transgenic mice overproducing CRH. Furthermore, the effects of mild stress on HPA axis activity and body temperature were investigated in these mice. Pre- and post-synaptic 5-HT1A receptor function were studied by monitoring body temperature and plasma corticosterone levels after challenge with the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propyl-amino)-tetralin (8-OH-DPAT). Hypothermia in response to 8-OH-DPAT treatment did not differ between transgenic and wild type mice, indicating unaltered somatodendritic 5-HT1A autoreceptor function in mice overproducing CRH. In wild type mice 8-OH-DPAT increased plasma corticosterone levels, but not in transgenic animals. CRH injection, however, increased corticosterone levels in both groups. These data suggest desensitization of post-synaptic, but not pre-synaptic, 5-HT1A receptors in mice overproducing CRH. These findings resemble those seen in depressed patients following 5-HT1A challenge, which is in accord with the hypothesized role of CRH in the pathogenesis of depression.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12884973     DOI: 10.1034/j.1601-183x.2002.10305.x

Source DB:  PubMed          Journal:  Genes Brain Behav        ISSN: 1601-183X            Impact factor:   3.449


  7 in total

1.  Treatment of depressive-like behaviour in Huntington's disease mice by chronic sertraline and exercise.

Authors:  Thibault Renoir; Terence Y C Pang; Michelle S Zajac; Grace Chan; Xin Du; Leah Leang; Caroline Chevarin; Laurence Lanfumey; Anthony J Hannan
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 2.  Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder.

Authors:  Hymie Anisman
Journal:  J Psychiatry Neurosci       Date:  2009-01       Impact factor: 6.186

3.  RasGRF1 regulates the hypothalamic-pituitary-adrenal axis specifically in early-adolescent female mice.

Authors:  Belkis Gizem Uzturk; Shan-Xue Jin; Beverly Rubin; Christopher Bartolome; Larry A Feig
Journal:  J Endocrinol       Date:  2015-08-05       Impact factor: 4.286

4.  Sexually dimorphic serotonergic dysfunction in a mouse model of Huntington's disease and depression.

Authors:  Thibault Renoir; Michelle S Zajac; Xin Du; Terence Y Pang; Leah Leang; Caroline Chevarin; Laurence Lanfumey; Anthony J Hannan
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

5.  The biology of fear- and anxiety-related behaviors.

Authors:  Thierry Steimer
Journal:  Dialogues Clin Neurosci       Date:  2002-09       Impact factor: 5.986

6.  Formyl peptide receptor as a novel therapeutic target for anxiety-related disorders.

Authors:  Irene Gallo; Lorenza Rattazzi; Giuseppa Piras; Thomas Gobbetti; Elisabetta Panza; Mauro Perretti; Jeffrey W Dalley; Fulvio D'Acquisto
Journal:  PLoS One       Date:  2014-12-17       Impact factor: 3.240

7.  Characterizing the postnatal hypothalamic-pituitary-adrenal axis response of in utero heat stressed pigs at 10 and 15 weeks of age.

Authors:  Jacob M Maskal; Luiz F Brito; Alan W Duttlinger; Kouassi R Kpodo; Betty R McConn; Christopher J Byrd; Brian T Richert; Jeremy N Marchant; Donald C Lay; Shelbi D Perry; Matthew C Lucy; Tim J Safranski; Jay S Johnson
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.